Ravi Kaul Email & Phone Number | I have more than 30 years of academic and industry experience in developing serology-based multiplex assays for the diagnosis of bacterial and viral infections, including autoimmune disorders. I have taken Vasculitis, anti-phospholipid syndrome (APLS) IgG, IgM and IgA, herpes simplex virus (HSV) 1 and 2 IgG, Vitamin D, Syphilis, RPR as well as Lyme disease projects from concept to commercialization. In the process, I have participated in pre-submission and 510(k) review meetings with the FDA staff. Over the years, I have established partnerships with external and internal collaborators. My other accomplishments include more than 50 peer reviewed publications and abstracts, multiple patents, speaking engagements and review for scientific journals. One recent publication in Clinical Chemistry describing the use of surrogate viral neutralization test against SARS-CoV2 variants was cited in the AACC smart briefs.

Ravi Kaul

I have more than 30 years of academic and industry experience in developing serology-based multiplex...
Davis, California, United States

*50 free lookup(s) per month.

Ravi Kaul’s Phone Numbers

Get RAVI’s Phone Number (For Free)

Social Media

Ravi Kaul’s Location Davis, California, United States

Ravi Kaul’s Current Industry

Ravi Kaul’s Prior Industry University Of California Davis | University Of Alberta | The National Institutes Of Health

Find accurate emails & phone numbers for over 700M professionals.

Research And Development Manager

Present

Adjunct Associate Professor

1993-01-01 00:00:00 - 2001-01-01 00:00:00

Assistant Professor

1989-01-01 00:00:00 - 1993-01-01 00:00:00

Postdoctoral Fellow

1981-01-01 00:00:00 - 1982-01-01 00:00:00

No Skills Available

No Languages Available

Ravi Kaul is a I have more than 30 years of academic and industry experience in developing serology-based multiplex assays for the diagnosis of bacterial and viral infections, including autoimmune disorders. I have taken Vasculitis, anti-phospholipid syndrome (APLS) IgG, IgM and IgA, herpes simplex virus (HSV) 1 and 2 IgG, Vitamin D, Syphilis, RPR as well as Lyme disease projects from concept to commercialization. In the process, I have participated in pre-submission and 510(k) review meetings with the FDA staff. Over the years, I have established partnerships with external and internal collaborators. My other accomplishments include more than 50 peer reviewed publications and abstracts, multiple patents, speaking engagements and review for scientific journals. One recent publication in Clinical Chemistry describing the use of surrogate viral neutralization test against SARS-CoV2 variants was cited in the AACC smart briefs.

Ravi Kaul has prior
experience in the following industries:
University Of California Davis | University Of Alberta | The National Institutes Of Health

Ravi Kaul has the following professional experience:
Bio Rad Laboratories | University Of California Davis | University Of Alberta | The National Institutes Of Health